Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
 Disease Category: Diabetes Mellitus, Type 2
Location: United States, NC

Trial Information

Type 2 Diabetes Trial for patients taking more than 1500 mg of Metformin daily

The purpose of this study is to assess the overall safety and tolerability of a single intravenous injection vs. placebo in patients with Type 2 Diabetes inadequately controlled on a stable Metformin regimen.

Patient Inclusion Criteria:

  • Aged between 18 and 80
  • Diagnosed with Type 2 Diabetes for at least 1 year
  • On a stable dose of more than 1500 mg of Metformin daily for at least 3 months

Patient Exclusion Criteria:

  • Currently smoking more than 10 cigarettes a day
  • Insulin therapy within the last 6 months
  • Use of prescription or over the counter weight lowering agent within the last 12 weeks

Mary Preisel, Marketing/Clinical Research Coordinator
American Health Research
1918 Randolph Rd, Suite 440
Charlotte, NC 28207
Phone: 704-325-6700
Email: Mpreisel@ahres.com

View Map

Research Center Information: American Health Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.